Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States
Antimicrobial resistance is a global public health threat, and gram-negative bacteria, such as Enterobacterales and <i>Pseudomonas aeruginosa,</i> are particularly problematic with difficult-to-treat resistance phenotypes. To reduce morbidity and mortality, a reduction in the time to eff...
Saved in:
Main Authors: | Kenneth P. Klinker (Author), Levita K. Hidayat (Author), Eric Wenzler (Author), Joan-Miquel (Author), Mary Motyl (Author), C. Andrew DeRyke (Author), Karri A. Bauer (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
β-lactam susceptibility in extended-spectrum β-lactamase-producing isolates
by: Gopal Nandlal Agrawal, et al.
Published: (2017) -
Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
by: Giacomo Luci, et al.
Published: (2021) -
Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations
by: Darren J. Bentley
Published: (2024) -
The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations
by: Abdullah Tarık Aslan, et al.
Published: (2022) -
Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance
by: Anna Duda-Madej, et al.
Published: (2023)